A literature review on the clinical and epidemiological aspects of Monkeypox
DOI:
https://doi.org/10.33448/rsd-v11i9.31612Keywords:
Monkeypox; Epidemiology; Clinical.Abstract
Smallpox was considered eradicated from the face of the earth. Monkeypox was discovered about 60 years ago and remains under surveillance in the health sector. It is a zoonotic infection that remains endemic in Central and West Africa in animal reservoirs, with increasing numbers of human cases and some outbreaks reported. Known by the name of Monkeypox, it is caused by a double-stranded DNA virus that belongs to the genus Orthopoxvirus in the family Poxviridae. Lymphadenopathy was a prominent feature of monkeypox disease. The main routes of infection are largely by respiratory droplet or percutaneous or mucosal contact. The time of exposure and onset of fever varies from 10 to 14 days, and the interval between exposure and the appearance of the rash varies from 12 to 16 days. Fever is accompanied by headache, myalgia, back pain, malaise and prostration, in addition to a rash 1 to 3 days after the onset of fever. The interval between fever and rash. The aim of this study is to review through the scientific literature the importance of an integral approach to the clinical and epidemiological aspects of Monkeypox, monkeypox. There are no specific treatments for monkeypox virus infection. Monkeypox symptoms usually resolve spontaneously. It is advised to avoid touching any injury to the mouth or eyes. Smallpox vaccination helps prevent or alleviate monkeypox disease.
References
Alakunle, E., Moens, U., Nchinda, G., & Okeke, M. I. (2020). Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution. Viruses, 12(11), 1257. https://doi.org/10.3390/v12111257
Alerta Epidemiológico Varíola do macaco em países não endêmicos - 20 de maio de 2022 - OPAS/OMS | Organização Pan-Americana da Saúde. (2022). Paho.org. https://www.paho.org/pt/documentos/alerta-epidemiologico-variola-do-macaco-em-paises-nao-endemicos-20-maio-2022
Alerta Epidemiológico Varíola do macaco em países não endêmicos 20 de maio de 2022. (n.d.). https://www.paho.org/pt/file/109125/download?token=3iyzGpEK
Beer, E. M., & Rao, V. B. (2019). A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLOS Neglected Tropical Diseases, 13(10), e0007791. https://doi.org/10.1371/journal.pntd.0007791
Damon, I. K. (2011). Status of human monkeypox: clinical disease, epidemiology and research. Vaccine, 29, D54–D59. https://doi.org/10.1016/j.vaccine.2011.04.014
Diaz, J. H. (2021). The Disease Ecology, Epidemiology, Clinical Manifestations, Management, Prevention, and Control of Increasing Human Infections with Animal Orthopoxviruses. Wilderness & Environmental Medicine, 32(4), 528–536. https://doi.org/10.1016/j.wem.2021.08.003
Domingues, C. M. A. S., Fantinato, F. F. S. T., Duarte, E., & Garcia, L. P. (2019). Vacina Brasil e estratégias de formação e desenvolvimento em imunizações. Epidemiologia E Serviços de Saúde, 28(2). https://doi.org/10.5123/s1679-49742019000200024
Doshi, R. H., Guagliardo, S. A. J., Doty, J. B., Babeaux, A. D., Matheny, A., Burgado, J., Townsend, M. B., Morgan, C. N., Satheshkumar, P. S., Ndakala, N., Kanjingankolo, T., Kitembo, L., Malekani, J., Kalemba, L., Pukuta, E., N’kaya, T., Kangoula, F., Moses, C., McCollum, A. M., & Reynolds, M. G. (2019). Epidemiologic and Ecologic Investigations of Monkeypox, Likouala Department, Republic of the Congo, 2017. Emerging Infectious Diseases, 25(2), 281–289. https://doi.org/10.3201/eid2502.181222
Forattini, O. P. (1988). Varíola, erradicação e doenças infecciosas. Revista de Saúde Pública, 22(5), 371–374. https://doi.org/10.1590/s003489101988000500001
LEVI, G. C., & KALLÁS, E. G. (2002). Varíola, sua prevenção vacinal e ameaça como agente de bioterrorismo. Revista Da Associação Médica Brasileira, 48(4), 357–362. https://doi.org/10.1590/s0104-42302002000400045
Moore, M., & Zahra, F. (2022, May 22). Monkeypox. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK574519/
Nakoune, E., & Olliaro, P. (2022). Waking up to monkeypox. BMJ, o1321. https://doi.org/10.1136/bmj.o1321
Nasir, I., Dangana, A., Ojeamiren, I., & Emeribe, A. (2018). Reminiscing the recent incidence of monkeypox in Nigeria: Its ecologic-epidemiology and literature review. Port Harcourt Medical Journal, 12(1), 1. https://doi.org/10.4103/phmj.phmj_47_17
Núñez-Gómez, M. C., Sánchez-Martínez, M. C., & Quevedo V., E. (2021). Viruela en Santiago, Concepción y Santafé: comparación de las estrategias higienistas ilustradas (1782-1807). Revista Ciencias de La Salud, 19. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.10594
Oladoye, M. J. (2021). Monkeypox: A Neglected Viral Zoonotic Disease. European Journal of Medical and Educational Technologies, 14(2), em2108. https://doi.org/10.30935/ejmets/10911
Petersen, E., Abubakar, I., Ihekweazu, C., Heymann, D., Ntoumi, F., Blumberg, L., Asogun, D., Mukonka, V., Lule, S. A., Bates, M., Honeyborne, I., Mfinanga, S., Mwaba, P., Dar, O., Vairo, F., Mukhtar, M., Kock, R., McHugh, T. D., Ippolito, G., & Zumla, A. (2019). Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era. International Journal of Infectious Diseases, 78, 78–84. https://doi.org/10.1016/j.ijid.2018.11.008
Schatzmayr, H. G. (2001). A varíola, uma antiga inimiga. Cadernos de Saúde Pública, 17(6), 1525–1530.https://doi.org/10.1590/s0102-311x2001000600024
Sklenovská, N., & Van Ranst, M. (2018). Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans. Frontiers in Public Health, 6. https://doi.org/10.3389/fpubh.2018.00241
Varíola dos macacos: o que é a doença, seus sintomas e por que ela afeta humanos. (2022). Butantan.gov.br. https://butantan.gov.br/covid/butantan-tira-duvida/tira-duvida-noticias/variola-dos-macacos-o-que-e-a-doenca-seus-sintomas-e-por-que-ela-afeta-humanos
Whitehouse, E. R., Bonwitt, J., Hughes, C. M., Lushima, R. S., Likafi, T., Nguete, B., Kabamba, J., Monroe, B., Doty, J. B., Nakazawa, Y., Damon, I., Malekani, J., Davidson, W., Wilkins, K., Li, Y., Radford, K. W., Schmid, S., Pukuta, E., Muyamuna, E., & Karhemere, S. (2020). Clinical and Epidemiologic Findings from Enhanced Monkeypox Surveillance in Tshuapa Province, Democratic Republic of the Congo During 2011–2015. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3720719
Whittemore, R., & Knafl, K. (2005). The integrative review: updated methodology. Journal of Advanced Nursing, 52(5), 546–553. https://doi.org/10.1111/j.1365-2648.2005.03621.x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Larissa Toloy Bigaran; Talita Costa Barbosa; Bruna Maia Barrachi; Paulo Francisco Nogueira de Souza Fuza; José Eduardo Azero Alssuffi; Maria Eduarda Azero Alssuffi; Bruno Henrique Silva Orta; Vitória Caroline de Macedo; Fabiana Parrilha Marinelli; Rodrigo Eduardo de Almeida Lima; Ewerton de Souza; Fernanda Coraline Campos Pereira; Elizabete Melo Montanari Fedocci; Elenberg Chaves de Paula
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
